XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 131 filers reported holding XENON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,881 | -29.1% | 150,840 | -21.7% | 0.01% | -27.3% |
| Q1 2024 | $8,298 | -5.3% | 192,752 | +1.3% | 0.01% | -8.3% |
| Q4 2023 | $8,766 | +39.0% | 190,312 | +3.1% | 0.01% | +33.3% |
| Q3 2023 | $6,307 | -11.3% | 184,632 | +0.0% | 0.01% | 0.0% |
| Q2 2023 | $7,108 | +909.7% | 184,631 | +838.2% | 0.01% | +800.0% |
| Q1 2023 | $704 | +7.2% | 19,679 | +18.2% | 0.00% | 0.0% |
| Q4 2022 | $657 | -99.9% | 16,650 | +4.1% | 0.00% | 0.0% |
| Q3 2022 | $578,000 | +18.7% | 16,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $487,000 | +38.4% | 16,000 | +39.1% | 0.00% | – |
| Q1 2022 | $352,000 | +39.1% | 11,500 | +42.0% | 0.00% | – |
| Q4 2021 | $253,000 | – | 8,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,754,266 | $107,388,831 | 7.33% |
| Altium Capital Management LP | 360,600 | $14,059,794 | 5.74% |
| Affinity Asset Advisors, LLC | 994,227 | $38,764,911 | 4.47% |
| First Light Asset Management, LLC | 1,306,260 | $50,931,077 | 4.46% |
| Nan Fung Group Holdings Ltd | 106,680 | $4,159,453 | 4.44% |
| Ally Bridge Group (NY) LLC | 169,369 | $6,603,697 | 3.93% |
| TLS Advisors LLC | 32,956 | $1,285 | 3.22% |
| BRAIDWELL LP | 2,560,573 | $99,836,741 | 3.13% |
| Paradigm Biocapital Advisors LP | 2,043,280 | $79,667,487 | 3.05% |
| BRIDGER MANAGEMENT, LLC | 146,800 | $5,723,732 | 2.94% |